Clinical Data (CLDA) Inactive 10-Q2006 Q3 Quarterly report

Filed: 14 Feb 06, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: accident, accidental, accomplish, accredited, accreted, accretive, Additionally, advantage, affiliated, affirmative, affirmatively, afford, agent, announced, appointment, arrangement, assigned, assisted, attached, attention, attractive, automation, awaiting, back, balloon, banning, belief, beneficial, bid, block, breach, bring, bringing, broaden, broader, broadly, broker, build, buyer, California, candidate, capable, capacity, Carolina, case, cast, cease, Chairman, chemical, choose, circumvented, claim, cleanup, collectibility, commit, comparison, compatible, compete, competing, concentrated, conclusion, confidential, confidentiality, Connecticut, consecutive, consummated, consummation, contaminated, contamination, contractual, conversion, copy, costly, counted, covenant, daily, damage, declared, deductible, defense, degree, Delaware, delivered, delivery, Deloitte, demand, Department, deposit, depression, devote, difficulty, discount, discounted, dispersed, disrupt, disruption, dissuade, distraction, diversion, diverting, division, Dr, easily, effectuate, effort, employing, encounter, encourage, enforcement, environment, environmental, equitable, event, evidence, evolution, exert, expended, expenditure, expertise, extensive, face, facilitate, factor, factual, fail, failure, fiduciary, filled, firm, flawed, float, food, forced, forfeited, forty, frequently, Friday, fundamental, fundraising, globally, growth, guarantee, handling, harm, heavily, hold, hope, hurt, important, impose, inaccurate, incomplete, incorrect, independent, independently, Individually, infringement, infringing, inherent, inherently, inhibited, injunctive, injury, installation, insufficient, invalidated, IPRD, Island, key, La, lack, largest, LaSalle, law, lawsuit, leasehold, leave, lender, lengthy, liability, liable, license, licensing, longer, lucrative, mandatory, manner, Master, meaningfully, member, merged, milestone, Nasdaq, nature, North, Notwithstanding, obsolete, OEM, offer, offering, oral, ordinary, outcome, output, overhang, ownership, patent, patentable, penalty, penetration, Pennsylvania, permit, permitting, personal, persuading, persuasive, Phase, placement, premium, prepayment, presence, preserving, President, prevent, prevented, previously, priority, producing, prohibitive, project, projected, promote, pursue, pursued, qualified, qualify, quickly, quorum, quotient, ratably, ratify, reached, reassignment, recoup, redeem, redeemed, redemption, refund, refundable, registered, regulatory, reliant, relief, relinquish, rely, remediate, remediation, render, resignation, resigned, resolution, retire, retirement, reuse, review, reviewed, Rhode, safety, Salle, satisfaction, satisfy, scale, science, scope, scrutiny, sell, senior, significantly, simultaneously, single, slowly, specialist, stage, Stricter, stronger, submission, submit, submitted, subsequent, succeed, successful, sued, suite, sum, supply, tactic, thereunder, Touche, toxic, traditional, training, transfer, trial, twelve, twenty, typically, unable, unallocated, unanticipated, unauthorized, uncertain, uncertainty, unenforceable, unfamiliar, unfavorable, uniform, unnecessary, unpaid, unpredictable, unsuccessful, unsuitable, USDA, viable, vilazadone, vilazodone, virtue, volume, waiver, widely, widespread, workforce, write, XMark

Removed: attributed, check, code, composed, computer, Employer, Identification, IRS, issuer, past, policy, preceding, ratio, shorter, Telephone, Washington

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

CLDA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

STATEMENT PURSUANT TO 18 U.S.C. SECTION 1350

In connection with the Quarterly Report on Form 10-Q of Clinical Data, Inc. (the “Company”) for the period ended December 31, 2005, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Israel M. Stein MD, Chief Executive Officer and President of the Company, and Mark D. Shooman, Senior Vice President and Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, that:

(1) Based on my knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) Based on my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the end of such period.


		/s/ Israel M. Stein MD

Date: February 14, 2006		Israel M. Stein MD
		Chief Executive Officer, President

		/s/ Mark D. Shooman

Date: February 14, 2006		Mark D. Shooman
		Senior Vice President & Chief Financial Officer